For example, HNRNPA2B1 could enhance the expression of the oncogenic isoforms of many tumor suppressor genes (e.g., RON, BIN1, WWOX, and c-FLIP) in glioma by modulating the splicing of these genes, thereby promoting glioma progression and aggressiveness (86). This evidence concerns the gene MST1R and central nervous system cancer.